11/02/2020

Chinese Journal of Tuberculosis and Respiratory Diseases recommended the use of Pirfenidone as an anti-fibrosis therapy for COVID-19 patients in China

08/14/2020

Notice of land acquisition by Beijing Continent Pharmaceutical Co., Ltd.

04/30/2020

Selected 140th in the ranking of Financial Times High-Growth Companies Asia-Pacific 2020

03/24/2020

A study to evaluate the efficacy and safety of Pirfenidone for the novel Coronavirus infection 2

03/17/2020

Update on Coronavirus epidemic

03/10/2020

Supporting a study to evaluate the efficacy and safety of Pirfenidone

03/02/2020

Fourth update on Coronavirus epidemic in China

02/12/2020

Social contribution for coronavirus epidemic in China

02/12/2020

Third update on Coronavirus epidemic in China

01/31/2020

Update on Coronavirus epidemic in China

01/23/2020

Coronavirus Outbreak Update

01/06/2020

New Year Greeting